Cite
HARVARD Citation
Prasad, B. et al. (2020). Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients. Canadian journal of kidney health and disease =. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prasad, B. et al. (2020). Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients. Canadian journal of kidney health and disease =. p. . [Online].